Our healthcare team has been working with the University of Colorado over the past couple of years to overcome critical data challenges in healthcare… and the results are exciting. In this blog post, I’ll share how the academic medical center was able to improve security, reduce maintenance, and increase efficiency in support of the university’s […]
Posts Tagged ‘personalized medicine’
Health Data Compass supports a multi-pronged analytics initiative for breakthroughs in personalized medicine – tailored medical services based on an individual’s predicted response or risk of disease – and integrates data from two major hospital systems, a physician billing plan, and scientific laboratories at the University of Colorado Denver. Perficient helped redesign and re-platform Health […]
On January 8, 2016, the FDA issued a warning letter that caught my attention. I can’t remember why I initially opened it; maybe because the company’s name had “pharm” in it, as opposed to “seafood” (which seems to be there a lot!). Once inside the letter, I found this in the opening paragraph: “This […]
Multiple Myeloma Research Foundation (MMRF) founder Kathy Giusti attended the Precision Medicine Initiative (PMI) summit several weeks ago, which was hosted by President Barack Obama. In a Forbes guest post, she shared five reasons why we can be optimistic about the initiative, which aims to develop better, targeted therapies that leverages one’s unique genetic […]
According to STAT, Vice President Joe Biden is meeting with over a dozen of the nation’s top cancer researchers today to talk about regulatory questions revolving around precision medicine. As you might recall, Biden’s son, Beau, recently died of brain cancer at the age of 46.
HIT Consultant, a digital publication focused on healthcare technology, recently shared a report by Reed Smith on mergers and acquisitions (M&A) in life sciences and how personalized medicine is playing an important role in many of today’s transactions. While pharmaceutical and biotechnology companies have not abandoned the “one-size-fits all” approach to developing drugs, many […]
Thanks to one of my LinkedIn contacts, I was introduced to a newly released “scorecard” that ranks pharmaceutical and biotechnology companies based on their precision medicine efforts. In essence, the organizations who made the cut are the ones moving precision medicine forward. They’re the ones focused on leveraging biomarkers to develop new therapies.
A few days ago, I read an article in The Atlantic about precision medicine. But it wasn’t about developing drugs for individuals with specific biomarkers. Instead, it discussed a simpler form of precision medicine that can prevent serious adverse events (SAEs). This method can actually fit in your wallet. It’s a card that houses […]
Since President Obama’s State of the Union address in January, much has been said about precision medicine. And, rightly so. The ability to treat common and rare diseases based on genomic and patient data is showing incredible promise. However, the medical community agrees that significant changes need to be made to federal healthcare policies […]